GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (SZSE:300759) » Definitions » Cyclically Adjusted PS Ratio

Pharmaron Beijing Co (SZSE:300759) Cyclically Adjusted PS Ratio : 5.51 (As of Jun. 09, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Pharmaron Beijing Co's current share price is ¥19.55. Pharmaron Beijing Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was ¥3.55. Pharmaron Beijing Co's Cyclically Adjusted PS Ratio for today is 5.51.

The historical rank and industry rank for Pharmaron Beijing Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300759' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.51   Med: 6.22   Max: 7.7
Current: 5.51

During the past 10 years, Pharmaron Beijing Co's highest Cyclically Adjusted PS Ratio was 7.70. The lowest was 5.51. And the median was 6.22.

SZSE:300759's Cyclically Adjusted PS Ratio is ranked worse than
50.2% of 504 companies
in the Biotechnology industry
Industry Median: 5.47 vs SZSE:300759: 5.51

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pharmaron Beijing Co's adjusted revenue per share data of for the fiscal year that ended in Dec23 was ¥6.499. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥3.55 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pharmaron Beijing Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Pharmaron Beijing Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Cyclically Adjusted PS Ratio Chart

Pharmaron Beijing Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 8.17

Pharmaron Beijing Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 8.17 -

Competitive Comparison of Pharmaron Beijing Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Pharmaron Beijing Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaron Beijing Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Cyclically Adjusted PS Ratio falls into.



Pharmaron Beijing Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Pharmaron Beijing Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=19.55/3.55
=5.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaron Beijing Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Pharmaron Beijing Co's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=6.499/117.2957*117.2957
=6.499

Current CPI (Dec23) = 117.2957.

Pharmaron Beijing Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.000 99.707 0.000
201512 0.000 102.015 0.000
201612 1.437 103.225 1.633
201712 1.722 104.984 1.924
201812 2.188 107.622 2.385
201912 2.527 110.700 2.678
202012 2.877 109.711 3.076
202112 4.090 112.349 4.270
202212 5.780 114.548 5.919
202312 6.499 117.296 6.499

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pharmaron Beijing Co  (SZSE:300759) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Pharmaron Beijing Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaron Beijing Co (SZSE:300759) Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.
Executives
Lou Xiao Qiang Directors, executives
Zheng Bei Directors, executives

Pharmaron Beijing Co (SZSE:300759) Headlines

No Headlines